Ireland-based Mallinckrodt will buy US rival Questcor Pharmaceuticals in a roughly $US5.6 billion ($A6.05 billion) cash-and-stock deal expected to expand the firm's drive in the specialty drugs field, the companies say. The acquisition was …
SBS3y
QCOR - News) shares increased 0.40 percent to close at $65.53 a share Tuesday. The stock traded between $64.59 …
It's better news for Agios Pharmaceuticals (AGIO). The stock ended up over 25% after the company reported promising results in the first clinical trial of its leukemia drug. Questcor Pharmaceutical (QCOR)was one of the top trending …
Few local stocks have been unscathed in 2008 in what is turning out to be the worst year for stocks since 1931, based on returns for the Standard & Poor’s 500 index. Shares of barely more than a dozen Silicon Valley stocks are higher now …
These companies are selected based on a number of requirements, including having an annual revenue between $5 million and $1 billion, they need to have traded for more than a year, and boast a stock price ... on their way up. Questcor
ANAHEIM — Mallinckrodt is buying Anaheim-based Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.2 billion. Mallinckrodt makes a range of specialty pharmaceuticals. Questcor's primary product is …
In the five years after the big Acthar price increase in August 2007, Questcor shares rose from around 60 cents to about $50, in one of the best performances of any stock in any industry. But in September, the shares plummeted after …
According to the complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges on …
Mallinckrodt is buying Anaheim's Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.6 billion that will help to further diversify the Irish company's business. Mallinckrodt makes a range of specialty …